You are here
National University Singapore
As one of only five institutions in Singapore awarded a $172 million “Research Centre of Excellence” grant by the government, the Cancer Science Institute (CSI) of Singapore at the National University of Singapore (NUS) is dedicated to investigating the pathogenesis of cancer and creating innovative, safer methods of diagnosis and treatment. Established on 15 October 2008, the institute has over 300 scientists and students, and is spearheaded by Professor Daniel G. Tenen, a world-leader in the field of transcriptional regulation, hematopoiesis, and cancer.
CSI houses a full spectrum of basic and clinical translational facilities with a multitude of state-of-the- art core support technologies. These sophisticated technologies provide robust investigational resources for CSI and also the wider NUS community.
NUS joined the SyStemAge consortium in April 2015.